Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 8,254 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: weight Clear all

Conditions: Patent Ductus Arteriosus (PDA)
Interventions: PDA Coil; Device
Lead sponsor: PFM Medical, Inc; Industry
Eligibility: 6 Months to 21 Years
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 11
States / cities: Loma Linda, California • Los Angeles, California • Madera, California + 8 more

Conditions: Deep Venous Thrombosis, Pulmonary Embolism
Interventions: Enoxaparin, Fondaparinux; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity
Interventions: Standard weight loss intervention, Standard weight loss intervention plus technology, Technology only; Behavioral
Lead sponsor: John M. Jakicic, PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Carcinoma, Hepatocellular
Interventions: Onartuzumab, Sorafenib; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 5
States / cities: Sarasota, Florida • Baltimore, Maryland • New York, New York + 2 more

Conditions: Duchenne Muscular Dystrophy
Interventions: Deflazacort; Drug
Lead sponsor: PTC Therapeutics; Industry
Eligibility: 4 Years and older · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 4
States / cities: Los Angeles, California • Chicago, Illinois • Rochester, New York + 1 more

Conditions: Breast Neoplasms, Breast Cancer, Cancer of Breast, Cancer of the Breast
Interventions: Bright blue-green light using light visor cap, Dim red light using light visor cap, European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire, Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Patient-Reported Outcomes Measurement Information System (PROMIS)-Sleep Disturbance, Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer-Fatigue, Digital foot candle datalogging light meter (Extech Instrument, Model SDL400), Polysomnography (Easy Ambulatory 2 Cadwell, Kennewick, WA), Horne-Ostberg Morningness-Eveningness Questionnaire, Daily Fatigue and Sleep Log; Other · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years and older · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Colon Cancer
Interventions: grilled hamburger (7 oz) with no vegetables, grilled hamburger (7 oz) with steamed broccoli and Brussels sprouts (3g/kg body weight combined), grilled hamburger (7 oz) with steamed parsnips, fresh parsley, and celery sticks (3g/kg body weight combined), grilled hamburger (7 oz) with steamed broccoli, Brussels sprouts, and parsnips plus fresh parsley and celery sticks (6g/kg body weight combined).; Other
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Irritable Bowel Syndrome With Diarrhea
Interventions: Ibodutant 10 mg, Placebo; Drug
Lead sponsor: Menarini Group; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 535 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 65
States / cities: Huntsville, Alabama • Sherwood, Arizona • Little Rock, Arkansas + 56 more

Conditions: Cystic Fibrosis
Interventions: Losartan, placebo; Drug
Lead sponsor: University of Miami; Other
Eligibility: 12 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 4
States / cities: Birmingham, Alabama • Miami, Florida • Kansas City, Kansas + 1 more

Conditions: Metastatic Pancreatic Cancer
Interventions: Anamorelin Hydrochloride, Placebo; Drug
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Down Syndrome, Gross Motor Delay, Cerebral Palsy
Interventions: Permobil Explorer Mini, Portable Mobility Aid for Children (PUMA); Device
Lead sponsor: University of Washington; Other
Eligibility: 12 Months to 60 Months
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Urinary Tract Infections
Interventions: Gentamicin, Standard of Care; Drug
Lead sponsor: Mercy Health Ohio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Obesity
Interventions: TAP® Micro Select Device (Touch Activated Phlebotomy); Device
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Medford, Massachusetts

Conditions: Obesity, Childhood, Metabolic Syndrome
Interventions: FIT, Home-Based Family Support; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 12 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Inflammation at Mini-screw Insertion Site, Mobility, Mini-screw
Interventions: Amoxicillin, Placebo oral capsule; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 12 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Body Weight, Overweight
Interventions: Endoscopic gastric restrictive procedure; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 4
States / cities: Miami, Florida • Boston, Massachusetts • Paterson, New Jersey + 1 more

Conditions: Diabetes Mellitus, Type 2
Interventions: High-Fruit Diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 20 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Esophageal Cancer
Interventions: Chemotherapy, Radiation Therapy, Surgery, MRI Imaging, Blood Draws; Radiation · Procedure · Device + 1 more
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Overweight, Body Weight
Interventions: Weight Watchers Online 2015 Program, Electronic Scale with Feedback; Behavioral · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Providence, Rhode Island • Knoxville, Tennessee

Conditions: Energy Expenditure
Interventions: One-A-Day Weight S.A. (Multi-Vitamins, BAY94-9350), Caffeine, Placebo; Dietary Supplement · Drug
Lead sponsor: Bayer; Industry
Eligibility: 25 Years to 45 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Physical Inactivity, Sedentary Behavior, Cardiometabolic Health
Interventions: Exercise Snacking; Behavioral
Lead sponsor: University of Wisconsin, River Falls; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: River Falls, Wisconsin

Conditions: Obesity
Interventions: Nutrisystem; Behavioral
Lead sponsor: University of Kentucky; Other
Eligibility: 25 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Cystic Fibrosis
Interventions: Linezolid; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Up to 18 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Sarcopenia
Interventions: Outpatient Muscle Biopsy; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

Nit-Occlud PDA Post-Approval Study

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention

A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Bright Light on Fatigue in Women Being Treated for Breast Cancer

Vegetable Intake Effect on Heterocyclic Amine Metabolism

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Losartan and Inflammation in Cystic Fibrosis

Anamorelin Study for Advanced Pancreatic Cancer

Up, Down, and All Around: Evaluating Mobility Devices for Young Children With Developmental Disabilities and Delays

Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting

A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss

FIT Families Multicomponent Obesity Intervention for African American Adolescents

Antibiotics Prior to Mini-screw Implant Insertion

Endoscopic Suturing for Primary Obesity Treatment

Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes

A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION

Weight Watchers Online 2015

Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women.

Exercise Snacking and Cardiometabolic Health

The Effect of Nutrisystem Meal Provision on Weight

Pharmacokinetics of Linezolid in Children With Cystic Fibrosis

A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy